HOYA Vision Care and Haag-Streit Partner to Combat Myopia
HOYA Vision Care, a leader in optical technology innovation today announced a strategic partnership with Haag-Streit, a renowned manufacturer and provider of ophthalmic instruments and medical equipment, to help address the global rise of myopia in children. The global sales and marketing agreement creates a preferred partnership between HOYA Vision Care and Haag-Streit to provide Eye Care Professionals (ECPs) with LENSTAR Myopia by HOYA to provide diagnostics and treatment for myopia.
Study Demonstrates a 2.5-fold Increase in Myopia Incidence in Children During COVID-19
The researchers consider that it is not possible to predict the axial length based only on optometric data, such as the corneal radius of curvature and the spherical equivalent
Children with first prescription before the age of 10 years showed the strongest progression and a significantly final Spherical Equivalent (SER). All children who developed SER ≤−3 D at 10 years were highly myopic as adults, children who had SER between −1.5 D and −3 D at 10 years had 46.0% risk of high myopia, and children with SER between −0.5 D and −1.5 D had 32.6% risk of high myopia.
New player for measuring eye length with myopia management software. The Lenstar is a well-known eye length measurement device and is now available with the Myopia Update.
MyopiaCare and Myappia inside.
Dear MyopiaCare Friends
We sincerely thank you for your confidence in our project and wish you and your family a Merry Christmas and a Happy, Healthy New Year!
Your MyopiaCare Team
the MyopiaCare Team
Soft contact lenses for myopia control in children is safe. Clinical charts review of almost 1000 children over more than 2 years.
Direct link to study
Vivior – Objektive Messdaten zur Ermittlung der Risikofaktoren bei Myopie
Mit dem Vivior Monitor werden erstmalig individuelle Sehverhaltensdaten während einer mehrtägigen Tragezeit gewonnen.Darauf basierend können personalisierte Sehkorrekturlösungen umgesetzt werden. Aufgrund der objektiven Beurteilung der Verhaltensrisiken wird im Myopie Bericht eine persönliche und Algorithmus gestützte Verhaltensempfehlung für das Kind abgegeben. Mehr Informationen unter:
Interesting podcast talk between Review of Myopia Management and the leader of the AAO Myopia task force.
Excited to see the white papers and cooperation of the international associations in ophthalmology.
Efficacy in myopia control
No single method of treatment shows clear superiority with the best of orthokeratology, SMCLs, spectacles and atropine showing similar effect with some caveats.
Johnson & Johnson Vision’s Approach to Myopia Management with Noel Brennan
Is late Sleeping a risk factor for myopia development?
Is optometry ready for myopia control? Education and other barriers to the treatment of myopia. by Saoirse McCrann, Ian Flitcroft,, James Loughman
Second licensing of Bausch&Lomb this week for myopia therapy products. A new player enters the myopia https://www.biospectrumasia.com/news/101/16936/bausch-health-bhvi-join-hands-for-myopia-control-contact-lens.html
Bausch Health licenses Eyenovia’s new treatment option to reduce childhood myopia progression
Recommandation officielle de l’Association française d’ophtalmologie sur le contrôle de la myopie
Essilor announces the first data from the study of its new Stellest lens for myopia management.
More than 60% slow-down in myopia progression when compared to the control group wearing single vision lenses
The eye clinic here in #Lausanne has launched a new brochure and website with lots of information about #children’s #eyes.
Really well done with lots of information. Not only for those concerned 😉
Available in 4 languages 🇨🇭 🇮🇹 🇩🇪 🇫🇷 🇬🇧